Pharma

Swiss multinational pharma, Novartis, has agreed to acquire Myricx Bio, a UK-based biotech company developing a new class of ADCs, using N-myristoyltransferase inhibitor (NMTi)...

In its second major deal announcement of the week following news of its proposed acquisition of Memo Therapeutics for in excess of €700m, France...

Nasdaq-listed Kimball Electronics, a US based contract manufacturing organisation (CMO), has acquired Helvoet Polymer Technologies, a Netherlands-based (CDMO) focused on microfluidics, diagnostics, and drug...

Canada-based Klick Health, an independent commercialisation partner for life sciences, has announced the acquisition of UK-based Oxford PharmaGenesis, the largest independent company in the healthcare communications...

Global CRO, Caidya, has announced a strategic combination with UK-based CRO, Simbec-Orion, designed to close the divide between early scientific insight and global clinical execution. The combination...

G Square, an investment firm specialising in the healthcare sector, is acquiring approximately 82% of the share capital of Valtecne, an Italy-based listed contract...

Orifarm, a Denmark-headquartered family-owned pharmaceutical company with leading positions across generics, prescription medicines, and over-the-counter healthcare products, is strengthening its focus on pharmaceuticals by...

UK-based Eumar Technology, a specialist medical device manufacturer serving the global wound care market, has acquired Hybrisan, which specialises in advanced wound care innovation,...

Laprophan Group, one of Morocco's leading pharmaceutical groups, has completed the acquisition of a controlling stake in Rivopharm, a Switzerland-based pharmaceutical company generating annual revenues...

Purna Pharmaceuticals, a specialty CDMO based in Belgium, has appointed Marc Verbruggen as managing director. Verbruggen joins Purna from Normec Healthcare Belgium, where he was...